Khoo T, Lilleker J, Thong B, Leclair V, Lamb J, Chinoy H
Nat Rev Rheumatol. 2023; 19(11):695-712.
PMID: 37803078
DOI: 10.1038/s41584-023-01033-0.
Fortanier E, Delmont E, Kouton L, Corazza G, Grapperon A, Verschueren A
J Neurol. 2023; 271(1):410-418.
PMID: 37740740
DOI: 10.1007/s00415-023-11986-7.
Lindgren U, Hedberg-Oldfors C, Pullerits R, Lindberg C, Oldfors A
J Neurol. 2023; 270(11):5483-5492.
PMID: 37498322
PMC: 10576680.
DOI: 10.1007/s00415-023-11878-w.
Michelle E, Pinal-Fernandez I, Casal-Dominguez M, Albayda J, Paik J, Tiniakou E
Neurology. 2023; 100(13):e1406-e1417.
PMID: 36690456
PMC: 10065210.
DOI: 10.1212/WNL.0000000000206777.
Namsrai T, Parkinson A, Chalmers A, Lowe C, Cook M, Phillips C
Orphanet J Rare Dis. 2022; 17(1):420.
PMID: 36411487
PMC: 9677896.
DOI: 10.1186/s13023-022-02570-9.
Epidemiology, Survival, and Clinical Characteristics of Inclusion Body Myositis.
Lindgren U, Pullerits R, Lindberg C, Oldfors A
Ann Neurol. 2022; 92(2):201-212.
PMID: 35596584
PMC: 9541152.
DOI: 10.1002/ana.26412.
Survival and associated comorbidities in inclusion body myositis.
Naddaf E, Shelly S, Mandrekar J, Chamberlain A, Hoffman E, Ernste F
Rheumatology (Oxford). 2021; 61(5):2016-2024.
PMID: 34534271
PMC: 9071572.
DOI: 10.1093/rheumatology/keab716.
Epidemiology and Natural History of Inclusion Body Myositis: A 40-Year Population-Based Study.
Shelly S, Mielke M, Mandrekar J, Milone M, Ernste F, Naddaf E
Neurology. 2021; 96(21):e2653-e2661.
PMID: 33879596
PMC: 8205447.
DOI: 10.1212/WNL.0000000000012004.
The Low Prevalence of Inclusion Body Myositis in an Outpatient Rheumatology Myositis Cohort.
Edigin E, Hassan A, Mathur T, Manadan A
Cureus. 2020; 12(8):e9873.
PMID: 32963913
PMC: 7500712.
DOI: 10.7759/cureus.9873.
The Impact of Dysphagia in Myositis: A Systematic Review and Meta-Analysis.
Labeit B, Pawlitzki M, Ruck T, Muhle P, Claus I, Suntrup-Krueger S
J Clin Med. 2020; 9(7).
PMID: 32650400
PMC: 7408750.
DOI: 10.3390/jcm9072150.
Dysphagia in Patients with Sporadic Inclusion Body Myositis: Management Challenges.
Mohannak N, Pattison G, Hird K, Needham M
Int J Gen Med. 2019; 12:465-474.
PMID: 31824189
PMC: 6901064.
DOI: 10.2147/IJGM.S198031.
Update on Inclusion Body Myositis.
Jabari D, Vedanarayanan V, Barohn R, Dimachkie M
Curr Rheumatol Rep. 2018; 20(8):52.
PMID: 29955981
DOI: 10.1007/s11926-018-0755-z.
Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis.
Lilleker J, Rietveld A, Pye S, Mariampillai K, Benveniste O, Peeters M
Ann Rheum Dis. 2017; 76(5):862-868.
PMID: 28122761
PMC: 5530338.
DOI: 10.1136/annrheumdis-2016-210282.
Development and evaluation of a standardized ELISA for the determination of autoantibodies against cN-1A (Mup44, NT5C1A) in sporadic inclusion body myositis.
Kramp S, Karayev D, Shen G, Metzger A, Morris R, Karayev E
Auto Immun Highlights. 2016; 7(1):16.
PMID: 27858337
PMC: 5114199.
DOI: 10.1007/s13317-016-0088-8.
Mortality and Causes of Death in Patients with Sporadic Inclusion Body Myositis: Survey Study Based on the Clinical Experience of Specialists in Australia, Europe and the USA.
Price M, Barghout V, Benveniste O, Christopher-Stine L, Corbett A, de Visser M
J Neuromuscul Dis. 2016; 3(1):67-75.
PMID: 27854208
PMC: 5271419.
DOI: 10.3233/JND-150138.
Targeting protein homeostasis in sporadic inclusion body myositis.
Ahmed M, Machado P, Miller A, Spicer C, Herbelin L, He J
Sci Transl Med. 2016; 8(331):331ra41.
PMID: 27009270
PMC: 5043094.
DOI: 10.1126/scitranslmed.aad4583.
Demographic and clinical features of inclusion body myositis in North America.
Paltiel A, Ingvarsson E, Lee D, Leff R, Nowak R, Petschke K
Muscle Nerve. 2015; 52(4):527-33.
PMID: 25557419
PMC: 4869122.
DOI: 10.1002/mus.24562.
Ongoing developments in sporadic inclusion body myositis.
Machado P, Ahmed M, Brady S, Gang Q, Healy E, Morrow J
Curr Rheumatol Rep. 2014; 16(12):477.
PMID: 25399751
PMC: 4233319.
DOI: 10.1007/s11926-014-0477-9.
Sporadic inclusion body myositis: the genetic contributions to the pathogenesis.
Gang Q, Bettencourt C, Machado P, Hanna M, Houlden H
Orphanet J Rare Dis. 2014; 9:88.
PMID: 24948216
PMC: 4071018.
DOI: 10.1186/1750-1172-9-88.
Inclusion body myositis: a case of bilateral extremity weakness.
Lam L, Scheper S, Zagorski N, Chung M, Noguchi H, Liow K
Hawaii J Med Public Health. 2013; 72(12):417-20.
PMID: 24377075
PMC: 3872918.
